Next Article in Journal
Activation of ERBB4 in Glioblastoma Can Contribute to Increased Tumorigenicity and Influence Therapeutic Response
Next Article in Special Issue
Ovarian Cancer Immunotherapy: Preclinical Models and Emerging Therapeutics
Previous Article in Journal / Special Issue
Can Stemness and Chemoresistance Be Therapeutically Targeted via Signaling Pathways in Ovarian Cancer?
 
 
Review

Article Versions Notes

Cancers 2018, 10(8), 242; https://doi.org/10.3390/cancers10080242
Action Date Notes Link
article xml file uploaded 24 July 2018 12:17 CEST Original file -
article xml uploaded. 24 July 2018 12:17 CEST Update https://www.mdpi.com/2072-6694/10/8/242/xml
article pdf uploaded. 24 July 2018 12:17 CEST Version of Record https://www.mdpi.com/2072-6694/10/8/242/pdf
article html file updated 24 July 2018 12:18 CEST Original file -
article html file updated 2 August 2018 15:36 CEST Update -
article html file updated 28 August 2018 04:50 CEST Update -
article html file updated 30 March 2019 23:41 CET Update -
article html file updated 15 April 2019 18:53 CEST Update -
article html file updated 29 April 2019 23:40 CEST Update -
article html file updated 5 October 2019 22:29 CEST Update -
article html file updated 10 February 2020 02:45 CET Update -
article html file updated 16 July 2022 23:42 CEST Update https://www.mdpi.com/2072-6694/10/8/242/html
Back to TopTop